Cardiomyopathy, Hypertrophic, Familial
"Cardiomyopathy, Hypertrophic, Familial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An autosomal dominant inherited form of HYPERTROPHIC CARDIOMYOPATHY. It results from any of more than 50 mutations involving genes encoding contractile proteins such as VENTRICULAR MYOSINS; cardiac TROPONIN T; ALPHA-TROPOMYOSIN.
| Descriptor ID |
D024741
|
| MeSH Number(s) |
C14.280.238.100.500 C14.280.484.150.070.160.500 C16.320.160
|
| Concept/Terms |
Cardiomyopathy, Hypertrophic, Familial- Cardiomyopathy, Hypertrophic, Familial
- Cardiomyopathy, Familial Hypertrophic
- Cardiomyopathies, Familial Hypertrophic
- Familial Hypertrophic Cardiomyopathies
- Hypertrophic Cardiomyopathies, Familial
- Hypertrophic Cardiomyopathy, Familial
- Familial Hypertrophic Cardiomyopathy
- Ventricular Hypertrophy, Familial
- Familial Ventricular Hypertrophies
- Familial Ventricular Hypertrophy
- Hypertrophy, Familial Ventricular
- Ventricular Hypertrophies, Familial
- Ventricular Hypertrophy, Hereditary
- Asymmetric Septal Hypertrophy, Familial
- Hereditary Ventricular Hypertrophy
- Hereditary Ventricular Hypertrophies
- Hypertrophies, Hereditary Ventricular
- Hypertrophy, Hereditary Ventricular
- Ventricular Hypertrophies, Hereditary
|
Below are MeSH descriptors whose meaning is more general than "Cardiomyopathy, Hypertrophic, Familial".
- Diseases [C]
- Cardiovascular Diseases [C14]
- Heart Diseases [C14.280]
- Cardiomyopathies [C14.280.238]
- Cardiomyopathy, Hypertrophic [C14.280.238.100]
- Cardiomyopathy, Hypertrophic, Familial [C14.280.238.100.500]
- Heart Valve Diseases [C14.280.484]
- Aortic Valve Stenosis [C14.280.484.150]
- Aortic Stenosis, Subvalvular [C14.280.484.150.070]
- Cardiomyopathy, Hypertrophic [C14.280.484.150.070.160]
- Cardiomyopathy, Hypertrophic, Familial [C14.280.484.150.070.160.500]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Cardiomyopathy, Hypertrophic, Familial [C16.320.160]
Below are MeSH descriptors whose meaning is more specific than "Cardiomyopathy, Hypertrophic, Familial".
This graph shows the total number of publications written about "Cardiomyopathy, Hypertrophic, Familial" by people in this website by year, and whether "Cardiomyopathy, Hypertrophic, Familial" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 2 | 0 | 2 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2012 | 3 | 1 | 4 |
| 2013 | 2 | 0 | 2 |
| 2014 | 2 | 0 | 2 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cardiomyopathy, Hypertrophic, Familial" by people in Profiles.
-
Bonaventura J, Rowin EJ, Maron MS, Maron BJ. Is Hypertrophic Cardiomyopathy Always a Familial and Inherited Disease? J Am Heart Assoc. 2023 06 20; 12(12):e028974.
-
Maron BJ, Rowin EJ, Maron MS. Global Burden of Hypertrophic?Cardiomyopathy. JACC Heart Fail. 2018 05; 6(5):376-378.
-
Weissler-Snir A, Hindieh W, Gruner C, Fourey D, Appelbaum E, Rowin E, Care M, Lesser JR, Haas TS, Udelson JE, Manning WJ, Olivotto I, Tomberli B, Maron BJ, Maron MS, Crean AM, Rakowski H, Chan RH. Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (?-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy. Circ Cardiovasc Imaging. 2017 Feb; 10(2).
-
Maron BJ, Weiner HL, Maron MS, Roberts WC. Surviving malignant hypertrophic cardiomyopathy with all major complications in a single patient. Am J Cardiol. 2015 Feb 01; 115(3):402-4.
-
Biagini E, Olivotto I, Iascone M, Parodi MI, Girolami F, Frisso G, Autore C, Limongelli G, Cecconi M, Maron BJ, Maron MS, Rosmini S, Formisano F, Musumeci B, Cecchi F, Iacovoni A, Haas TS, Bacchi Reggiani ML, Ferrazzi P, Salvatore F, Spirito P, Rapezzi C. Significance of sarcomere gene mutations analysis in the end-stage phase of hypertrophic cardiomyopathy. Am J Cardiol. 2014 Sep 01; 114(5):769-76.
-
Kane DA, Triedman J. Post-mortem genetic testing in a family with long-QT syndrome and hypertrophic cardiomyopathy. Cardiovasc Pathol. 2014 Mar-Apr; 23(2):107-9.
-
Rowin EJ, Maron MS. The ever expanding spectrum of phenotypic diversity in hypertrophic cardiomyopathy. Am J Cardiol. 2013 Aug 01; 112(3):463-4.
-
Maron MS. A paradigm shift in our understanding of the development of the hypertrophic cardiomyopathy phenotype?: not so fast! Circulation. 2013 Jan 01; 127(1):10-2.
-
Maron BJ, Maron MS, Semsarian C. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives. J Am Coll Cardiol. 2012 Aug 21; 60(8):705-15.
-
Spoladore R, Maron MS, D'Amato R, Camici PG, Olivotto I. Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence. Eur Heart J. 2012 Jul; 33(14):1724-33.